Doc #120 — Eyecare: Vision Correction, Eye Disease, and Ophthalmic Services

---

RECOMMENDED ACTIONS

Phase 1 — First weeks

1. Include all eyecare stocks in the national consumable inventory (Doc #1, Doc #8). Count: spectacle lenses (finished and semi-finished blanks) in optical retail and laboratory stocks, contact lens inventory at distributors and retailers, contact lens solution stocks, ophthalmic pharmaceutical stocks (glaucoma drops, anti-VEGF agents, antibiotics, steroids, mydriatics, anaesthetics), intraocular lens (IOL) inventory at hospitals and surgical centres, and ophthalmic instrument inventory nationally. [First weeks]

2. Classify ophthalmic surgeons (ophthalmologists) and optometrists as essential personnel. NZ has approximately 200–250 practising ophthalmologists and approximately 900–1,100 practising optometrists.⁷⁸ Prevent redeployment to non-eye-related roles. [IMMEDIATE]

3. Suspend elective refractive surgery (LASIK, PRK, lens exchange for refractive purposes). These procedures consume surgical resources — excimer laser gases, surgical consumables, ophthalmic theatre time — that must be reserved for sight-saving procedures. [IMMEDIATE]

4. Issue guidance on contact lens transition. All contact lens wearers should transition to spectacles as soon as possible to conserve contact lens stocks for cases where spectacles are inadequate (high anisometropia, keratoconus, certain post-surgical situations). [First weeks]

Phase 1 — First months

5. Centralise IOL stocks. Every intraocular lens in NZ — in hospital stores, private surgical centres, distributor warehouses — must be inventoried and centrally allocated. IOLs are the binding constraint on cataract surgery (see Section 5). [Months 1–2]

6. Implement ophthalmic pharmaceutical rationing. Glaucoma drops, anti-VEGF agents, and ophthalmic antibiotics enter the pharmaceutical rationing framework (Doc #116). Priority allocation to patients at highest risk of irreversible vision loss. [Months 1–3]

7. Begin knowledge capture from dispensing opticians and optical laboratory technicians. The skills of lens surfacing, edging, fitting, and frame adjustment are currently held by a small workforce in optical laboratories. Document these processes in detail before institutional knowledge is lost. [Months 1–3]

8. Inventory all lens grinding and surfacing equipment nationally — optical laboratories (approximately 3–5 major labs plus smaller in-house operations), university physics and optics departments, amateur telescope-making clubs (who have directly relevant lens grinding skills). [Months 1–3]

Phase 2 — Years 1–3

9. Establish lens recycling programme. Collect spectacles from deceased persons, unclaimed lost property, and donations. Match salvaged lenses to patients by approximate prescription. An imperfect match (within 0.5–1.0 dioptres) provides functional improvement for most wearers, even if not optimal. [Year 1]

10. Begin trial production of optical glass blanks at the glass production facility (Doc #98, Section 8). Coordinate with Doc #110 (Eyeglass Lens Manufacturing) for surfacing capability development. [Year 1–2]

11. Train lens grinding apprentices. Target: 20–40 trained lens grinders nationally within 3 years, distributed across major population centres. Each grinder, with appropriate equipment, can produce approximately 5–15 finished single-vision lenses per day. [Years 1–3]

12. Develop frame production capability. Wire frames from NZ-produced copper wire (Doc #70) or steel wire from NZ Steel wire rod (Doc #91); wooden frames from NZ timber; 3D-printed frames while printing capability remains. [Years 1–3]

Phase 3+ — Years 3–7

13. Scale domestic lens production toward meeting national demand. At 2 million lens-dependent people, even assuming only 50% need new lenses in a given 3-year period, production must reach hundreds of thousands of lenses per year. This requires multiple lens grinding workshops and reliable optical glass blank supply. [Years 3–5]

14. Develop reading glasses as a mass-produced item. Presbyopia affects virtually everyone over 45. Simple convex reading lenses in standard strengths (+1.00 to +3.50 in 0.25 or 0.50 steps) can be produced in quantity from NZ glass. These do not require individual prescriptions — patients self-select the strength that provides best near vision. This alone addresses the most common vision complaint in the adult population. [Years 2–4]

15. Establish regional ophthalmic surgical capability for cataract surgery using locally produced or salvaged IOLs, or aphakic correction (spectacles after lens removal) when IOLs are unavailable. [Years 3–7]

---

ECONOMIC JUSTIFICATION

The cost of uncorrected vision

The economic case for eyecare is among the strongest in the Recovery Library, because the consequences of inaction are large, quantifiable, and distributed across the entire workforce.

Labour productivity loss from uncorrected refractive error:

• Approximately 2 million NZ residents need corrective lenses.⁹ Of these, an estimated 800,000–1,200,000 are in the working-age population (15–64).
• Without correction, an estimated 30–50% of these workers experience functional impairment sufficient to reduce their productivity or exclude them from their current role.¹⁰ This represents 240,000–600,000 partially or fully impaired workers.
• If the average productivity reduction for an impaired worker is 20–50% (a rough estimate — some tasks are vision-critical, others are not), the national labour force loses the equivalent of 50,000–300,000 full-time workers.
• Under recovery conditions, where the workforce is already strained, this is a severe loss.

Cost of domestic lens production:

• A lens grinding workshop with one trained grinder, basic equipment (a manual lens generator, polishing equipment, and a lensometer for verification), and a supply of glass blanks requires approximately 1–2 person-years to establish and 1 person-year of ongoing labour per workshop.¹¹
• A network of 20–30 workshops nationally represents 20–60 person-years of establishment cost and 20–30 person-years of ongoing operation.
• Output: 20–30 workshops producing 5–15 lenses per grinder per day, operating 250 days per year = 25,000–112,500 lenses per year. At two lenses per pair, this is 12,500–56,000 pairs of spectacles per year.
• To serve the full lens-dependent population on a 3-year replacement cycle (approximately 670,000 pairs per year), production must eventually scale further — but even initial production addresses the most severe cases.

Breakeven: If domestic lens production restores the equivalent of 10,000 workers to full productivity (a conservative fraction of the 50,000–300,000 impaired), and each workshop costs 2 person-years to establish, 30 workshops (60 person-years of investment) recover their cost within the first year of operation. This is one of the highest-return investments in the Recovery Library.

Cataract surgery economics: Each cataract operation restores an individual from partial or complete blindness to functional vision. For a working-age adult, the return in productive years is very large. Even at a reduced surgical rate of 5,000–10,000 operations per year (compared to the pre-event 30,000–35,000), this represents thousands of people returned to the workforce annually.

---

1. NZ’S CORRECTIVE LENS DEPENDENCY

1.1 Who needs correction

The 2 million figure is an estimate based on NZ Health Survey data and international prevalence studies applied to NZ’s demographic profile.¹² The breakdown, approximately:

Condition	Estimated NZ prevalence	Functional impact without correction
Myopia (nearsightedness)	~1.2–1.5 million	Distance vision impaired; severity varies widely
Hyperopia (farsightedness)	~300,000–500,000	Near and sometimes distance vision impaired
Presbyopia (age-related near vision loss)	~1.2–1.5 million (all adults over ~45)	Cannot read or do close work; universal with age
Astigmatism (irregular curvature)	~500,000–800,000 (often combined with above)	Blurred vision at all distances; correctable with cylindrical lenses

These categories overlap significantly — a person with myopia and astigmatism counts once, not twice.

Severity distribution matters. Mild myopia (-0.50 to -2.00 dioptres) affects daily comfort but does not prevent most work. Moderate myopia (-2.00 to -6.00) causes significant distance impairment. Severe myopia (worse than -6.00, estimated 5–8% of myopes) is functionally disabling without correction — these individuals cannot recognise faces beyond arm’s length, cannot drive, and are at risk of falls and injury.¹³ The prioritisation framework (Section 7) weights severe refractive error highest.

1.2 Existing stock and depletion timeline

Spectacles: NZ’s approximately 1.6–1.8 million spectacle wearers collectively own an estimated 3–5 million pairs (many people have multiple pairs, old prescriptions, reading glasses, sunglasses with prescription).¹⁴ In addition, optical retailers and warehouses hold tens of thousands of finished spectacles and hundreds of thousands of semi-finished lens blanks.

Depletion drivers:

• Breakage and loss: Spectacle frames break, lenses scratch to unusability, and glasses are lost. Estimated annual attrition rate for spectacles in regular use: 15–25% of the wearing population needs replacement or repair in a given year.¹⁵ This represents 240,000–450,000 pairs per year.
• Prescription changes: Children’s prescriptions change rapidly (annual changes are normal). Adult myopia stabilises but presbyopia progresses relentlessly through the 40s, 50s, and 60s, requiring updated reading correction every 2–5 years. New presbyopes develop continuously as the population ages.
• Frame degradation: Metal frames corrode, plastic frames become brittle, hinges fail. Even with careful handling, a pair of spectacles has a practical lifespan of 3–7 years for daily use.

Timeline: Without domestic production, NZ’s effective spectacle stock — accounting for breakage, loss, prescription mismatch, and degradation — declines by roughly 15–25% per year from the pool of usable pairs. Within 3–5 years, a significant fraction of the lens-dependent population is wearing damaged, outdated, or improvised correction. Within 7–10 years, hundreds of thousands of people have no functional correction at all.

Contact lenses: Effectively unavailable within months. Daily disposables are consumed immediately. Monthly and extended-wear soft lenses last weeks to months but require solution that will deplete. Rigid gas-permeable (RGP) lenses are the most durable — lasting 1–3 years with proper care — but the small population of RGP wearers (estimated 10,000–30,000 in NZ) eventually loses these too.¹⁶ Contact lens wearers must transition to spectacles.

1.3 What cannot be replaced

Several categories of modern ophthalmic products are beyond NZ’s domestic production capability for the foreseeable future:

• High-index lenses (refractive index 1.60–1.74): Require specialty glass compositions with barium, lanthanum, or titanium additions that NZ does not produce or hold in significant stocks.¹⁷ Patients with strong prescriptions (worse than approximately -4.00 dioptres) will wear noticeably thicker, heavier lenses in standard crown glass — a -6.00 lens in crown glass (RI 1.52) is roughly 40–50% thicker at the edge than the same prescription in 1.67-index material.¹⁸
• Polycarbonate and CR-39 plastic lenses: Require petrochemical feedstocks and industrial polymerisation. NZ will revert to glass lenses — approximately 2 to 2.5 times heavier than CR-39 plastic for the same prescription, less impact-resistant, but optically adequate.¹⁹
• Anti-reflective, scratch-resistant, and photochromic coatings: These are vacuum-deposition or chemical processes requiring materials and equipment NZ cannot produce. Uncoated glass lenses reflect more light and scratch more easily, but function adequately.
• Progressive (varifocal) lenses: Require computer-controlled surface generation with sub-micron precision. NZ will revert to bifocal lenses (feasible — two different curvatures ground on the same lens, a technique dating to Benjamin Franklin) or separate reading and distance glasses. Bifocals lack the smooth intermediate-distance transition of progressives, producing an abrupt image jump at the segment boundary that some wearers find disorienting; carrying two pairs of glasses (distance and reading) avoids the image jump but is less convenient.²⁰
• Contact lenses: Require hydrogel polymers, silicone hydrogel materials, precision moulding, and sterile packaging. Not producible in NZ.
• Intraocular lenses (IOLs): Require PMMA or acrylic polymer, precision machining or injection moulding to sub-millimetre tolerances, and sterile packaging. Not producible in NZ (see Section 5).

---

2. NZ’S EYECARE WORKFORCE

2.1 Ophthalmologists

NZ has approximately 200–250 practising ophthalmologists — medically trained doctors who have completed specialist ophthalmic surgical training.²¹ They perform cataract surgery, glaucoma surgery, retinal procedures, oculoplastic surgery, and manage complex eye disease. They are concentrated in major centres — Auckland, Wellington, Christchurch, Hamilton, Tauranga, Dunedin — with limited coverage in rural areas.

Under recovery conditions: Ophthalmologists remain essential for surgical eye care. Their capacity is constrained not by their skills but by consumable supplies — IOLs for cataract surgery, surgical instruments that wear and break, ophthalmic pharmaceuticals, and functioning operating theatre infrastructure.

2.2 Optometrists

NZ has approximately 900–1,100 practising optometrists — primary eye health professionals who examine eyes, prescribe corrective lenses, detect eye disease, and (with therapeutic endorsement) treat certain conditions with medication.²² They are distributed more broadly than ophthalmologists, including in smaller towns. The University of Auckland School of Optometry and Vision Science is the sole NZ training institution.²³

Under recovery conditions: Optometrists become the frontline eyecare workforce. Their core skills — refraction (measuring refractive error), eye examination, and lens prescribing — require relatively simple equipment (a trial lens set, a retinoscope, an ophthalmoscope, a visual acuity chart). These instruments are durable and do not require consumables. An optometrist with a trial lens set can determine a patient’s prescription indefinitely, regardless of supply chain status.

Critical equipment: NZ’s optometrists currently rely on autorefractors, slit lamps, tonometers (for glaucoma screening), OCT scanners, and retinal cameras — all of which are electronic instruments that will eventually fail without replacement parts. The transition to manual techniques (retinoscopy instead of autorefraction, direct ophthalmoscopy instead of retinal imaging) is a return to methods that all optometrists learned in training but many rarely use. Refresher training in manual clinical techniques should begin early.²⁴

2.3 Dispensing opticians and optical technicians

Dispensing opticians fit and adjust spectacles and advise on lens selection. Optical laboratory technicians operate the surfacing and edging equipment that grinds raw lens blanks to prescription and fits them into frames. NZ has an estimated 500–800 dispensing opticians and perhaps 100–200 optical laboratory technicians.²⁵ These technicians are the people who know how to grind lenses — their skills are directly transferable to domestic lens production.

2.4 Orthoptists and other eye health workers

A small number of orthoptists (who assess and treat binocular vision disorders and strabismus) and ophthalmic nurses work within NZ’s eye health system. Their skills in managing specific conditions remain relevant but their numbers are small.

---

3. LENS GRINDING FROM NZ GLASS

3.1 The process

Lens grinding is the shaping of a glass disc (the lens blank) so that its front and back surfaces have specific curvatures that bend light to correct a patient’s refractive error. The process has been practised since the late 13th century and the fundamental principles have not changed.²⁶

Steps:

1. Obtain a lens blank — a disc of optical-quality glass, typically 65–75 mm diameter, 8–15 mm thick, with one surface pre-formed to a standard base curve (in modern practice) or flat (for manual generation). Doc #98 (Glass Production), Section 8 describes NZ production of optical glass blanks.

2. Generate the prescription surface — the back (concave) surface of the lens is ground to the curvature specified by the patient’s prescription. In modern practice, this is done with a computer-controlled surface generator. In manual practice, it is done with a cup-shaped metal grinding tool (called a lap) of the required radius, using abrasive slurry (silicon carbide or aluminium oxide grit in water). The blank is mounted on a block and held against the rotating lap. Progressively finer grits smooth the surface from rough-ground to fine-ground. NZ has silicon carbide (carborundum) stocks in industrial abrasive suppliers, and aluminium oxide can be salvaged from used grinding wheels or produced from alumina — NZ Aluminium Smelters at Tiwai Point holds alumina feedstock (Doc #109), which can be calcined to produce abrasive-grade aluminium oxide, though diverting alumina from aluminium production creates a competing resource demand.²⁷

3. Polish the surface — the fine-ground surface is polished to optical clarity using a polishing lap (typically felt or pitch) with a fine polishing compound (cerium oxide is standard; rouge — iron oxide — is the historical alternative). Polishing removes the last microns of surface roughness and produces the transparent, smooth surface required for a functional lens.

4. Verify the prescription — the finished lens is checked with a lensometer (also called a focimeter or vertometer) to confirm that the prescription matches what was ordered. Manual lensometers are simple optical instruments — a point light source, a target, a calibrated lens system, and a telescope — and are durable, requiring no power or consumables.

5. Edge the lens — the round lens is cut to the shape of the spectacle frame. In modern practice, this uses a computer-controlled edger that traces the frame shape. In manual practice, it is done with a hand edger (a diamond or carborundum wheel) or by chipping and grinding — slower but effective.²⁸

6. Fit to frame — the edged lens is mounted in the frame, aligned for the patient’s interpupillary distance and optical centre height, and the frame is adjusted to fit.

3.2 Equipment requirements

The minimum equipment for a functional lens grinding workshop:

Equipment	Function	NZ availability
Lens generator (manual or powered)	Rough-grinding the prescription curve	Existing units in optical labs; can be fabricated from a lathe with modifications (Doc #91)
Grinding laps (set of curvatures)	Fine-grinding to specific radii	Cast from metal (aluminium or brass) in NZ foundries (Doc #93)
Polishing laps	Final polishing to optical clarity	Pitch or felt on metal form; producible locally
Abrasive grits (SiC, Al₂O₃)	Grinding medium	Existing industrial stocks; eventual domestic production or trade
Polishing compound (CeO₂ or Fe₂O₃)	Final polish	Iron oxide (rouge) producible from NZ iron ore (see dependency chain below);29 cerium oxide requires import or trade
Lensometer (manual)	Prescription verification	Existing units in every optical practice; durable, long-lived
Lens clock (Geneva gauge)	Surface curvature measurement	Existing units; simple mechanical device
Trial lens set	Determining patient prescription	Existing units in every optometry practice; indestructible if cared for
Edging equipment	Shaping lens to frame	Existing diamond wheels; replaceable with carborundum

The dependency chain is short. Unlike many manufacturing processes in this library, lens grinding does not require a long chain of prerequisite industries. It requires glass blanks (Doc #98), abrasive grit (existing stocks, eventually domestic), polishing compound (iron oxide — produced by roasting NZ-sourced magnetite or limonite ore, then grinding to fine powder; requires a kiln or furnace and ball mill),³⁰ and metal laps (casting from aluminium or brass in NZ foundries, then machining to precise curvatures — Doc #93, Doc #91). The skills are the primary bottleneck — and they already exist in NZ’s optical laboratory workforce.

3.3 What domestic production can and cannot achieve

Can produce:

• Single-vision lenses for myopia, hyperopia, and presbyopia in standard crown glass (refractive index ~1.52)
• Bifocal lenses (a second segment ground or fused onto the main lens for near vision)
• Cylindrical corrections for astigmatism (requires generating a toric surface — more skill-intensive but standard lens grinding technique)
• Tinted lenses (by adding colourants to the glass batch or by surface treatment)

Cannot produce (or not without significant further development):

• Progressive (varifocal) lenses — require free-form surface generation with computer control
• High-index lenses — require specialty glass compositions
• Lightweight plastic lenses — require petrochemical feedstocks
• Coated lenses (anti-reflective, scratch-resistant, UV-filtering) — require vacuum deposition equipment
• Contact lenses — require polymer chemistry and precision moulding

3.4 Production rate estimates

A skilled manual lens grinder can produce approximately 5–15 single-vision lenses per day, depending on equipment quality and prescription complexity.³¹ This is far slower than a modern computer-controlled surfacing laboratory (which can produce hundreds per day), but it is the realistic rate for the manual equipment NZ will be using.

National production targets:

• Minimum viable: 10 workshops, 10 grinders, producing 50–150 lenses/day = 12,500–37,500 pairs/year. Serves the most severely impaired patients.
• Adequate for maintenance: 30 workshops, 30+ grinders, producing 150–450+ lenses/day = 37,500–112,000+ pairs/year. Begins to address the ongoing replacement need.
• Full replacement rate: ~670,000 pairs/year (replacing the full lens-dependent population on a 3-year cycle). This requires industrial-scale production beyond manual grinding — either rebuilt automated surfacing equipment or a very large number of manual workshops.

The realistic trajectory: manual production begins in Phase 2, scales through Phase 3, and reaches adequate-for-maintenance levels by Phase 4. Full replacement rate is a Phase 5+ goal.

---

4. EYE DISEASE MANAGEMENT WITHOUT MODERN DIAGNOSTICS

Phase 1 through Phase 4+ — medication-dependent management dominates Phase 1–2; surgical management dominates Phase 3+

4.1 Glaucoma

Glaucoma — optic nerve damage from elevated intraocular pressure (IOP) — affects an estimated 70,000–100,000 New Zealanders, with perhaps half undiagnosed.³² It is the leading cause of irreversible blindness in NZ. Management depends on IOP-lowering eye drops (principally prostaglandin analogues, beta-blockers, and carbonic anhydrase inhibitors), with surgical intervention (trabeculectomy, tube shunts) for cases not controlled by medication.

Under recovery conditions:

• Medication depletion: Glaucoma eye drops are imported. Stocks will deplete within 1–3 years depending on the drug (see Doc #116 for pharmaceutical rationing framework). Some drugs (timolol, a beta-blocker) may be producible domestically from available chemical precursors in the medium term (Doc #119). Others (prostaglandin analogues like latanoprost) require complex synthesis beyond NZ’s foreseeable capability.
• Monitoring: IOP measurement requires a tonometer. Goldmann applanation tonometers (the gold standard) are durable mechanical instruments that require only disposable prisms and fluorescein dye. Schiotz indentation tonometers are even simpler — a metal plunger on a calibrated scale, requiring no consumables at all. Screening for glaucoma can continue indefinitely with these instruments.³³
• Surgical management: Trabeculectomy (creating a drainage channel in the eye wall to lower IOP) is a procedure that NZ ophthalmologists can perform with basic microsurgical instruments, a functioning operating microscope, and local anaesthesia. It does not require implanted devices (though modern practice often uses anti-scarring agents like mitomycin C, which will deplete). Surgical management becomes the primary treatment as medication stocks are exhausted.³⁴
• Honest assessment: Some glaucoma patients will go blind. Those with advanced disease requiring multiple medications to maintain IOP control, who cannot tolerate or do not respond to surgery, will lose vision progressively as their medications deplete. This is not preventable under isolation. The triage framework (Section 7) addresses how to allocate depleting glaucoma medications to maximise the number of patients who retain functional vision.

4.2 Cataracts

See Section 5 (dedicated section due to the scale of the surgical challenge).

4.3 Diabetic retinopathy

An estimated 250,000–300,000 New Zealanders have diabetes, of whom approximately 25–30% have some degree of diabetic retinopathy, and approximately 5–7% have sight-threatening retinopathy requiring treatment.³⁵

Under recovery conditions:

• Screening: Retinal photography (the current NZ screening method) requires functioning digital cameras and software. As these fail, screening reverts to direct and indirect ophthalmoscopy — manual examination of the retina through a dilated pupil. This requires a skilled examiner, a functioning ophthalmoscope (a battery-powered or rechargeable instrument), and mydriatic drops (for pupil dilation — atropine can be extracted from plants of the Solanaceae family, though pharmaceutical-grade production requires chemistry capability).
• Treatment: Laser photocoagulation for diabetic retinopathy requires a functioning laser unit — a complex electronic instrument that will eventually fail without parts. When lasers are unavailable, cryotherapy (freezing treatment applied to the retina through the eye wall) is an older alternative that uses a cryoprobe cooled by nitrous oxide or carbon dioxide. Cryoprobe instruments are simpler than lasers and the cooling gases may be available from NZ industrial gas stocks. Anti-VEGF intravitreal injections (the current first-line treatment for diabetic macular oedema) require imported biologics that will deplete (Doc #116).³⁶
• The diabetes trajectory matters: If diabetes management deteriorates under recovery conditions (reduced medication availability, dietary changes, reduced monitoring — see Doc #3), the incidence and severity of diabetic retinopathy may actually decline in some patients as blood glucose levels fall with reduced caloric intake and increased physical activity, while worsening in others who lose glycaemic control entirely. The net effect is uncertain.

4.4 Age-related macular degeneration (AMD)

AMD is the leading cause of vision loss in NZ adults over 50. The “dry” form (90% of cases) has no effective treatment — it progresses slowly and management is supportive (magnification aids, lighting optimisation). The “wet” form (10% of cases) is treated with intravitreal anti-VEGF injections (ranibizumab, aflibercept, bevacizumab) — drugs that will deplete.

Under recovery conditions: Patients with wet AMD will lose central vision as anti-VEGF treatment becomes unavailable. This is among the harder allocation decisions in ophthalmic pharmaceutical rationing — each patient requires injections every 4–12 weeks indefinitely, consuming scarce medication for a condition that (unlike glaucoma) does not cause total blindness (peripheral vision is preserved). The triage framework must weigh this ongoing demand against the needs of glaucoma patients at risk of complete blindness.

4.5 Infections and trauma

Eye infections (bacterial conjunctivitis, corneal ulcers) and eye trauma (workplace injuries, burns, foreign bodies) require prompt treatment. Antibiotic eye drops will eventually deplete, but many ocular infections can be managed with:

• Saline irrigation — producible from NZ salt and clean water indefinitely
• Dilute povidone-iodine (5% for periocular skin, 1–2.5% for conjunctival use) — an effective broad-spectrum antiseptic whose active ingredient (iodine) NZ may be able to source from seaweed (Doc #81) or import via trade³⁷
• Honey-based preparations — Manuka honey (Leptospermum scoparium) has well-documented antimicrobial properties and has been used in ophthalmic applications (Optimel eye drops use Manuka honey as the active ingredient). Medical-grade honey is producible in NZ indefinitely.³⁸
• Basic surgical instruments for foreign body removal, drainage of orbital abscesses, and emergency procedures — durable if maintained

Eye trauma prevention becomes more important as protective equipment (safety glasses, face shields) depletes. Workshop and agricultural safety protocols must emphasise eye protection. Polycarbonate safety glasses from existing industrial stocks should be prioritised for high-risk workers (Doc #98, Section 3.4).

---

5. CATARACT SURGERY: THE IOL CONSTRAINT

IOL-based surgery: Phase 1–3 (stock-dependent). Aphakic surgery: Phase 3+ (indefinite).

5.1 Scale of the problem

Cataract — opacification of the eye’s natural crystalline lens — develops progressively with age and is accelerated by UV exposure (Doc #41). Under normal NZ conditions, approximately 30,000–35,000 cataract operations are performed per year, making it the most common surgical procedure in the country.³⁹ Under elevated UV-B from ozone depletion, cataract incidence will increase and the age of onset will decrease — more people needing surgery sooner.⁴⁰

Modern cataract surgery (phacoemulsification) involves removing the opacified natural lens through a small incision using ultrasonic fragmentation, then implanting a synthetic intraocular lens (IOL) — a small plastic lens (PMMA, acrylic, or silicone) that permanently replaces the natural lens and restores focus.

5.2 IOL inventory and depletion

NZ’s IOL inventory at any given time is estimated at 20,000–50,000 units in hospital stores, distributor warehouses, and private surgical centre stocks.⁴¹ At the pre-event surgical rate of 30,000–35,000 per year, this represents 7–18 months of supply. If the surgical rate is reduced (by suspending elective cases and operating only on patients with significant visual impairment), the stock lasts longer — perhaps 2–5 years.

This is a hard ceiling. When IOLs are gone, modern cataract surgery as currently practised is no longer possible. NZ cannot produce IOLs — they require precision polymer manufacture, optical quality control, and sterile packaging that are beyond foreseeable domestic capability.

5.3 Surgery without IOLs: aphakia

Before IOL implantation became standard in the 1980s, cataract surgery involved removing the opacified lens and leaving the patient “aphakic” — without a lens in the eye. Aphakic patients can see, but the eye’s focusing power is drastically reduced. Correction requires:

• Aphakic spectacles: Very thick convex lenses (approximately +10 to +12 dioptres) that restore functional vision but with significant optical distortion — magnification of approximately 25%, reduced peripheral vision, and a “swimming” effect when the head moves. These are uncomfortable and disorienting, particularly for monocular aphakia (one eye with a lens, one without — the magnification difference between eyes causes diplopia).⁴²
• Aphakic contact lenses: Would be preferable (less magnification, better peripheral vision) but contact lenses will not be available.

Honest assessment: Aphakic correction is substantially worse than IOL-corrected pseudophakia. Patients will notice the difference dramatically. But aphakic correction with spectacles is vastly better than untreated cataract blindness. NZ can produce thick convex aphakic spectacle lenses from domestic glass — the lens grinding capability described in Section 3 is directly applicable. The optical quality of aphakic spectacles is less demanding than standard corrective lenses because the patient’s expectations are calibrated by comparison with blindness, not with modern vision.

5.4 Surgical technique adaptation

When phacoemulsification machines fail (they are complex electronic instruments with finite service life), cataract surgery reverts to extracapsular cataract extraction (ECCE) — the standard technique of the 1970s–1980s. ECCE uses a larger incision (10–12 mm vs. 2–3 mm for phaco), manual expression of the cataractous lens nucleus, and suture closure of the wound. It requires:

• Basic microsurgical instruments (durable if maintained and sharpened)
• Operating microscope (a mechanical and optical instrument that can function for decades with lamp replacement — NZ’s grid provides power)
• Suture material (nylon sutures producible from fishing line stocks, or silk sutures from local production — Doc #44)
• Local anaesthesia (lidocaine, producible from local chemistry in the medium term — Doc #118)
• Sterile technique and an operating theatre

NZ ophthalmologists trained before the 1990s have direct experience with ECCE. Younger ophthalmologists have been trained in it as part of their specialty education but may have limited practical experience. Retraining in ECCE technique, including hands-on surgical simulation, should begin in Phase 1.⁴³

5.5 IOL allocation framework

Given finite IOL stocks, allocation must prioritise:

1. Bilateral cataracts in working-age adults (18–65): Maximum functional and economic return — restoring a blind worker to productivity.
2. Monocular cataract with the better eye already aphakic or impaired: Prevents complete dependence.
3. Bilateral cataracts in children and young adults: Paediatric cataracts cause amblyopia (permanent vision loss from disuse) if uncorrected; IOL implantation has the greatest lifetime benefit.
4. Unilateral cataract in working-age adults where aphakic spectacles would be poorly tolerated: Monocular aphakia creates intolerable image size difference between eyes.
5. Elderly patients with bilateral cataracts: Aphakic spectacles, while less comfortable, provide functional vision; the remaining productive years are fewer.

This framework prioritises workforce impact and lifetime benefit, consistent with the Recovery Library’s approach to scarce resource allocation (Doc #4, Doc #116). It is not comfortable. A 75-year-old who has paid taxes for 50 years receives lower priority for an IOL than a 30-year-old. The justification is functional: the IOL provides more total years of vision correction to the younger patient, and NZ’s recovery requires maximising the functional workforce. Aphakic spectacles still provide useful vision to the elderly patient. This reasoning should be communicated honestly if and when rationing is implemented; opacity about allocation criteria breeds distrust.

---

6. UV-RELATED EYE DAMAGE

Phase 1–4 (elevated UV persists 5–15 years post-event; ongoing at lower baseline thereafter)

6.1 The elevated UV environment

As detailed in Doc #41, ozone depletion from nuclear detonations increases UV-B radiation at the surface by an estimated 20–100%, with the effect persisting for 5–15 years. NZ’s already-extreme UV environment becomes substantially more hazardous.

6.2 Eye-specific UV effects

Photokeratitis (UV keratitis, “snow blindness”): Acute UV-B damage to the corneal epithelium causing intense pain, tearing, and temporary vision loss 6–12 hours after exposure. Recovers spontaneously within 24–48 hours with supportive care (dark room, cool compresses, analgesics). Prevention: UV-blocking eyewear for all outdoor exposure during high-UV periods. Treatment does not require imports.⁴⁴

Pterygium: A wedge-shaped growth of conjunctival tissue onto the cornea, strongly associated with chronic UV exposure. Common in NZ already (particularly in outdoor workers and Maori/Pacific populations). Increased UV will increase incidence. Surgical removal is a minor procedure performable with basic instruments; recurrence is common and re-operation may be needed.⁴⁵

Accelerated cataract formation: UV-B is the primary environmental risk factor for cortical cataracts.⁴⁶ Under elevated UV-B, the population develops cataracts earlier — possibly 5–10 years earlier than they otherwise would. This means more cataract surgeries needed sooner, accelerating IOL depletion. Prevention through UV-blocking eyewear is directly linked to extending IOL stocks and delaying the transition to aphakic surgery.

The link to eyewear stocks: Sunglasses and UV-blocking eyewear are dual-purpose — they prevent UV eye damage and they are, in many cases, prescription eyewear that also provides refractive correction. Lens production from NZ glass should incorporate UV-blocking properties where feasible. Standard crown glass (soda-lime-silica) blocks most UV-B naturally (glass is a reasonably effective UV filter below approximately 320 nm), providing incidental UV protection even in untinted corrective lenses.⁴⁷ For deliberate UV-blocking eyewear, tinting the glass with iron oxide or other colourants and/or increasing lens thickness enhances UV filtering.

---

7. PRIORITISATION FRAMEWORK FOR LIMITED EYECARE RESOURCES

All eyecare resources — optometrist time, ophthalmologist time, lens grinding capacity, IOLs, ophthalmic pharmaceuticals — are scarce and must be allocated.

7.1 Vision correction priority tiers

Priority	Population	Rationale
Tier 1 (Critical)	Severe refractive error (>-6.00 or >+4.00) in working-age adults; monocular vision patients; safety-critical occupations (surgeons, machine operators, vehicle drivers)	Uncorrected severe error = functional blindness; safety risk to self and others
Tier 2 (High)	Moderate refractive error (-2.00 to -6.00) in working-age adults; all children needing correction; presbyopic correction for workers in visually demanding roles (reading, precision work)	Significant productivity impairment; children’s visual development at risk
Tier 3 (Standard)	Mild refractive error in working-age adults; presbyopic correction for the general population	Comfort and quality of life; moderate productivity impact
Tier 4 (Deferred)	Cosmetic concerns; very mild errors causing minimal functional impact; non-working elderly with stable mild refractive error	Not vision-threatening; other priorities are higher

7.2 Ophthalmic pharmaceutical allocation

Integrated with the pharmaceutical rationing framework (Doc #116):

• Glaucoma medications: Allocated by risk of irreversible vision loss. Patients with advanced optic nerve damage on multiple drops: highest priority (most to lose). Patients with early glaucoma and mild pressure elevation: consider surgical intervention early rather than consuming medication.
• Anti-VEGF agents: Allocated to patients with the most to gain (younger patients with wet AMD or diabetic macular oedema threatening central vision). Patients with advanced dry AMD or already-severe vision loss: limited benefit from treatment.
• Ophthalmic antibiotics: Reserved for sight-threatening infections (corneal ulcers, endophthalmitis). Routine conjunctivitis: saline irrigation and time.

7.3 Surgical prioritisation

Cataract and other ophthalmic surgery prioritised by:

1. Sight-saving procedures (acute glaucoma, retinal detachment repair, endophthalmitis drainage, penetrating eye injuries)
2. Bilateral cataract causing legal blindness in working-age adults
3. Other cataracts per the IOL allocation framework (Section 5.5)
4. Pterygium causing visual axis obstruction
5. Strabismus surgery in children (prevents amblyopia)
6. Elective procedures — suspended until resources allow

---

8. CRITICAL UNCERTAINTIES

Uncertainty	Range	Impact
Actual NZ corrective lens dependency	1.5–2.3 million people	Determines scale of the production challenge
IOL inventory at time of event	20,000–50,000 units	Directly determines years of modern cataract surgery available
Rate of spectacle attrition	15–25% of wearers per year	Determines urgency of domestic lens production
UV-B increase magnitude and duration	20–100% increase, 5–15 years	Determines acceleration of cataract incidence
Optical glass blank quality achievable from NZ materials	Standard crown (~1.52 RI) to slightly better	Determines lens thickness and weight for strong prescriptions
Number of NZ residents with lens grinding skills	100–300 estimated (optical lab technicians, amateur opticians, telescope makers)	Determines training timeline
Glaucoma medication depletion timeline	1–3 years for most agents	Determines when surgical management must fully replace medical management
Phacoemulsification machine service life without parts	3–10 years (wide range, depends on usage and maintenance)	Determines when ECCE becomes the only surgical technique

---

9. CROSS-REFERENCES

• Doc #1 — National Emergency Stockpile Strategy: inclusion of ophthalmic supplies
• Doc #4 — Pharmaceutical and Medical Supply Management: integration of eye care into supply framework
• Doc #8 — National Asset and Skills Census: quantifying eyecare workforce, lens stocks, equipment
• Doc #41 — UV Protection: UV-related eye disease, sunglass stocks, UV-blocking eyewear
• Doc #44 — Fishing Gear: nylon fishing line as suture material source
• Doc #70 — Copper Wire Production: copper wire for spectacle frames
• Doc #81 — Aquaculture: seaweed as potential iodine source for povidone-iodine
• Doc #91 — Machine Shop Operations: fabrication of lens grinding equipment
• Doc #93 — Foundry Work: casting of metal grinding laps
• Doc #98 — Glass Production: optical glass blanks for lens production (Section 8)
• Doc #109 — Aluminum Smelting and Recycling: alumina as abrasive feedstock
• Doc #110 — Eyeglass Lens Manufacturing: detailed grinding and surfacing procedures (companion document)
• Doc #116 — Pharmaceutical Rationing and Shelf-Life Extension: ophthalmic pharmaceutical allocation
• Doc #118 — Anesthesia Alternatives: local anaesthesia for ophthalmic surgery
• Doc #119 — Local Pharmaceutical Production: potential domestic production of timolol and other ophthalmic agents
• Doc #122 — Mental Health: psychological impact of vision loss; communication of rationing decisions
• Doc #157 — Accelerated Trade Training: lens grinding apprenticeship programme

---

FOOTNOTES

---

1. New Zealand Health Survey data indicate that approximately 40% of adults report using corrective lenses. Extrapolated to the full population including children, an estimated 1.8–2.2 million NZ residents use corrective lenses. The precise figure is uncertain — the NZ Health Survey covers adults aged 15+, and the paediatric fraction is estimated from international myopia prevalence data for comparable populations. See: Ministry of Health, “New Zealand Health Survey,” annual series. https://www.health.govt.nz/nz-health-statistics/national-...↩︎

2. Contact lens use in NZ is estimated from Contact Lens Association of Ophthalmologists (CLAO) survey data and NZ industry estimates. The overlap between contact lens and spectacle wearers is significant — most contact lens wearers also own spectacles as backup.↩︎

3. Myopia prevalence and severity distribution data from Holden, B.A. et al., “Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050,” Ophthalmology, 2016. NZ-specific prevalence from NZ Health Survey and NZ Association of Optometrists.↩︎

4. Contact lens replacement schedules and material degradation rates are well-established in optometric practice. Daily disposables are single-use by design. Monthly soft lenses degrade within 4–8 weeks even with proper care. RGP lenses are more durable (1–3 years typical lifespan) but require specific cleaning solutions that will deplete.↩︎

5. Parengarenga Harbour (Far North District) contains NZ’s highest-purity silica sand deposits, with SiO₂ content of approximately 96–99%. These deposits have been intermittently mined and are the primary NZ source for glass-grade silica. Transport from Parengarenga to glass production facilities (Auckland region) requires approximately 400 km of road or coastal shipping. See: Christie, A.B. et al., “Mineral Wealth of New Zealand,” GNS Science, 2014.↩︎

6. Cataract surgery volume estimated from NZ Ministry of Health surgical procedure data. NZ performs approximately 30,000–35,000 cataract operations per year across public and private sectors. This figure has been increasing year-on-year due to population ageing and expanding surgical indications. See: Ministry of Health, “Publicly Funded Hospital Discharges,” annual reports. https://www.health.govt.nz/↩︎

7. Royal Australian and New Zealand College of Ophthalmologists (RANZCO) workforce data. NZ has approximately 200–250 practising ophthalmologists, with ongoing workforce shortage particularly in public hospital services. See: RANZCO workforce survey data. https://ranzco.edu/↩︎

8. Optometrists and Dispensing Opticians Board (ODOB) registration data. NZ has approximately 900–1,100 registered optometrists with practising certificates. See: https://www.odob.health.nz/↩︎

9. New Zealand Health Survey data indicate that approximately 40% of adults report using corrective lenses. Extrapolated to the full population including children, an estimated 1.8–2.2 million NZ residents use corrective lenses. The precise figure is uncertain — the NZ Health Survey covers adults aged 15+, and the paediatric fraction is estimated from international myopia prevalence data for comparable populations. See: Ministry of Health, “New Zealand Health Survey,” annual series. https://www.health.govt.nz/nz-health-statistics/national-...↩︎

10. Productivity impact of uncorrected refractive error is estimated from WHO studies and Lancet Global Health Commission on Global Eye Health. Specific NZ productivity data for uncorrected refractive error are not available; estimates are extrapolated from international studies. See: Burton, M.J. et al., “The Lancet Global Health Commission on Global Eye Health: vision beyond 2020,” The Lancet Global Health, 2021.↩︎

11. Lens grinding production rates for manual (hand-operated) lens surfacing equipment are estimated from historical optical manufacturing data and current practice in low-resource settings. Rates vary significantly with equipment quality, operator skill, and prescription complexity. Simple single-vision lenses are faster to produce than toric (astigmatic) corrections.↩︎

12. New Zealand Health Survey data indicate that approximately 40% of adults report using corrective lenses. Extrapolated to the full population including children, an estimated 1.8–2.2 million NZ residents use corrective lenses. The precise figure is uncertain — the NZ Health Survey covers adults aged 15+, and the paediatric fraction is estimated from international myopia prevalence data for comparable populations. See: Ministry of Health, “New Zealand Health Survey,” annual series. https://www.health.govt.nz/nz-health-statistics/national-...↩︎

13. Myopia prevalence and severity distribution data from Holden, B.A. et al., “Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050,” Ophthalmology, 2016. NZ-specific prevalence from NZ Health Survey and NZ Association of Optometrists.↩︎

14. Spectacle ownership estimates based on NZ market data and international comparisons. The average spectacle wearer in a developed country owns 2–3 pairs (current prescription, previous prescription, reading glasses, sunglasses). NZ-specific data from NZ Association of Optometrists and optical industry sources.↩︎

15. Annual spectacle replacement rate estimated from optical industry data. In normal conditions, approximately 30–40% of spectacle wearers purchase new spectacles annually (combining breakage, prescription changes, and fashion/upgrade purchases). Under recovery conditions, fashion-driven replacement ceases but breakage and prescription change persist, suggesting a 15–25% functional replacement need.↩︎

16. Contact lens replacement schedules and material degradation rates are well-established in optometric practice. Daily disposables are single-use by design. Monthly soft lenses degrade within 4–8 weeks even with proper care. RGP lenses are more durable (1–3 years typical lifespan) but require specific cleaning solutions that will deplete.↩︎

17. High-index optical glasses (1.60–1.74 refractive index) require barium oxide, lanthanum oxide, or titanium dioxide additions to the glass batch to increase refractive index. NZ has no known economic deposits of barium, lanthanum, or titanium suitable for optical glass production. For a -6.00 dioptre lens: edge thickness in crown glass (RI 1.52) is approximately 8–10 mm vs. 5–6 mm in 1.67-index material for a 50 mm diameter frame. See: Hecht, E., “Optics,” Addison-Wesley, 5th edition.↩︎

18. High-index optical glasses (1.60–1.74 refractive index) require barium oxide, lanthanum oxide, or titanium dioxide additions to the glass batch to increase refractive index. NZ has no known economic deposits of barium, lanthanum, or titanium suitable for optical glass production. For a -6.00 dioptre lens: edge thickness in crown glass (RI 1.52) is approximately 8–10 mm vs. 5–6 mm in 1.67-index material for a 50 mm diameter frame. See: Hecht, E., “Optics,” Addison-Wesley, 5th edition.↩︎

19. Standard crown glass (density approximately 2.5 g/cm³) compared with CR-39 plastic (density approximately 1.3 g/cm³). For a -4.00 dioptre lens in a typical frame, a glass lens weighs approximately 30–45 g vs. 15–22 g for the same prescription in CR-39. Glass lenses are also more susceptible to shattering on impact — a relevant safety consideration for workshop and agricultural workers, partially mitigated by using thicker lens profiles or side shields. See: Jalie, M., “The Principles of Ophthalmic Lenses,” Association of British Dispensing Opticians, 5th edition.↩︎

20. Bifocal lenses provide two discrete focal zones (distance and near) with an abrupt transition (“image jump”) at the segment boundary. Progressive lenses provide a continuous gradient of power from distance through intermediate to near vision. Approximately 40–50% of NZ’s current multifocal lens wearers use progressives; all will revert to bifocals or separate glasses. Adaptation is generally rapid for those who previously wore bifocals, but former progressive wearers report discomfort and task interference during the transition period (typically 2–4 weeks). See: Jalie, M., “The Principles of Ophthalmic Lenses.”↩︎

21. Royal Australian and New Zealand College of Ophthalmologists (RANZCO) workforce data. NZ has approximately 200–250 practising ophthalmologists, with ongoing workforce shortage particularly in public hospital services. See: RANZCO workforce survey data. https://ranzco.edu/↩︎

22. Optometrists and Dispensing Opticians Board (ODOB) registration data. NZ has approximately 900–1,100 registered optometrists with practising certificates. See: https://www.odob.health.nz/↩︎

23. University of Auckland School of Optometry and Vision Science is the sole NZ provider of optometry degrees (Bachelor of Optometry). Graduates approximately 50–60 new optometrists per year. See: https://www.auckland.ac.nz/en/fmhs/about-the-faculty/depa...↩︎

24. Manual refraction (retinoscopy) and direct ophthalmoscopy are core competencies taught in all NZ optometry training. However, clinical practice in modern NZ optometry relies heavily on automated instruments (autorefractors, OCT, visual field analysers). The extent to which current practitioners maintain proficiency in manual techniques varies. Refresher training programmes have been recommended by the NZ Association of Optometrists.↩︎

25. Dispensing optician and optical laboratory technician workforce numbers are less precisely known than optometrist or ophthalmologist numbers, as registration requirements differ. Estimates are based on ODOB data and optical industry employment figures.↩︎

26. The history of spectacle lens manufacture dates to the late 13th century in northern Italy (Venice, Florence). Lens grinding techniques were refined through the 17th and 18th centuries. See: Ilardi, V., “Renaissance Vision from Spectacles to Telescopes,” American Philosophical Society, 2007.↩︎

27. Silicon carbide (carborundum) is the standard abrasive for optical surfacing. NZ imports silicon carbide but maintains significant stocks in industrial abrasive supply chains (used in metalworking, stone cutting, and other applications). Aluminium oxide is an alternative abrasive. Abrasive supply is a consumable that must be tracked and rationed.↩︎

28. Manual lens edging techniques were standard practice in optical dispensing before computer-controlled edgers became widespread in the 1990s. Older dispensing opticians and optical technicians have direct experience with hand edging. The skill can be retrained from textbook descriptions if necessary.↩︎

29. Iron oxide (rouge) for optical polishing can be produced by roasting magnetite or limonite ore — both available in NZ’s West Coast and Taranaki ironsand deposits — to produce hematite (Fe₂O₃), then grinding to sub-micron particle size using a ball mill. The particle size and uniformity of the powder determine polishing quality; poorly graded rouge produces scratched lenses. Historical optical workshops achieved adequate polishing quality with hand-ground rouge, but the process requires several hours of grinding per batch. See: Twyman, F., “Prism and Lens Making,” Hilger & Watts, 1952.↩︎

30. Iron oxide (rouge) for optical polishing can be produced by roasting magnetite or limonite ore — both available in NZ’s West Coast and Taranaki ironsand deposits — to produce hematite (Fe₂O₃), then grinding to sub-micron particle size using a ball mill. The particle size and uniformity of the powder determine polishing quality; poorly graded rouge produces scratched lenses. Historical optical workshops achieved adequate polishing quality with hand-ground rouge, but the process requires several hours of grinding per batch. See: Twyman, F., “Prism and Lens Making,” Hilger & Watts, 1952.↩︎

31. Lens grinding production rates for manual (hand-operated) lens surfacing equipment are estimated from historical optical manufacturing data and current practice in low-resource settings. Rates vary significantly with equipment quality, operator skill, and prescription complexity. Simple single-vision lenses are faster to produce than toric (astigmatic) corrections.↩︎

32. Glaucoma NZ estimates approximately 70,000–100,000 NZ residents have glaucoma, with approximately half undiagnosed. See: https://www.glaucoma.org.nz/. International prevalence studies (Tham, Y.C. et al., “Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040,” Ophthalmology, 2014) support this estimate for NZ’s demographic profile.↩︎

33. Goldmann applanation tonometry and Schiotz indentation tonometry are well-established techniques that require minimal consumables. Goldmann tonometry requires fluorescein dye and single-use prisms (though prisms can be sterilised and reused if single-use supplies deplete). Schiotz tonometry requires no consumables at all.↩︎

34. Trabeculectomy is a proven glaucoma surgical technique that has been performed since the 1960s. Success rates without antimetabolites (mitomycin C, 5-fluorouracil) are lower than with them (approximately 60–70% IOP control at 5 years without antimetabolites vs. 80–90% with), but the procedure remains effective. See: Cairns, J.E., “Trabeculectomy: preliminary report of a new method,” American Journal of Ophthalmology, 1968.↩︎

35. Diabetes prevalence from Ministry of Health Virtual Diabetes Register. Diabetic retinopathy prevalence from the NZ National Diabetes Retinal Screening Programme. See: https://www.health.govt.nz/our-work/diseases-and-conditio...↩︎

36. Laser photocoagulation and cryotherapy for diabetic retinopathy are well-established treatments. The Diabetic Retinopathy Study (DRS) and Early Treatment Diabetic Retinopathy Study (ETDRS) demonstrated the efficacy of laser treatment. Cryotherapy was the standard treatment before laser became available and remains a viable alternative.↩︎

37. Povidone-iodine as an ophthalmic antiseptic is supported by extensive evidence. A 5% solution is used for periocular skin preparation; 1–2.5% is used for conjunctival irrigation (lower concentrations reduce corneal toxicity). WHO recommends povidone-iodine for ophthalmic prophylaxis in resource-limited settings. See: Isenberg, S.J. et al., “A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum,” New England Journal of Medicine, 1995.↩︎

38. Manuka honey (Leptospermum scoparium) has documented antimicrobial activity attributed to methylglyoxal content. Optimel Manuka+ eye drops are a TGA-listed product available in NZ and Australia. NZ is the world’s primary Manuka honey producer. See: Albietz, J.M. and Lenton, L.M., “Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease,” Cornea, 2006.↩︎

39. Cataract surgery volume estimated from NZ Ministry of Health surgical procedure data. NZ performs approximately 30,000–35,000 cataract operations per year across public and private sectors. This figure has been increasing year-on-year due to population ageing and expanding surgical indications. See: Ministry of Health, “Publicly Funded Hospital Discharges,” annual reports. https://www.health.govt.nz/↩︎

40. UV-B and cataract risk: McCarty, C.A. and Taylor, H.R., “A review of the epidemiologic evidence linking ultraviolet radiation and cataracts,” Developments in Ophthalmology, 2002. The Chesapeake Bay Watermen Study and Australian studies demonstrate dose-response relationship between cumulative UV-B exposure and cortical cataract risk.↩︎

41. IOL inventory estimate is based on NZ surgical volume and typical distributor stock levels. NZ’s IOL distributors (primarily Alcon, Johnson & Johnson Vision, Carl Zeiss Meditec) maintain buffer stocks, but these are calibrated to just-in-time supply chains and may represent only months of surgical demand.↩︎

42. Aphakic spectacle correction: standard ophthalmic optics. The approximately +10 to +12 dioptre correction required produces approximately 25–33% magnification, ring scotoma (peripheral vision gap), and pin-cushion distortion. These effects are well-documented and were familiar to all cataract patients before the IOL era (post-1980s). See: any ophthalmic optics textbook, e.g., Elkington, A.R. and Frank, H.J., “Clinical Optics,” Blackwell Scientific.↩︎

43. Extracapsular cataract extraction (ECCE) is taught as a component of ophthalmology specialty training in Australia and New Zealand (RANZCO training programme). The extent of hands-on ECCE experience among recently trained NZ ophthalmologists varies. The Fred Hollows Foundation provides ECCE training for ophthalmologists working in low-resource Pacific Island settings, and NZ ophthalmologists have participated in these programmes.↩︎

44. Photokeratitis: caused by UV-B absorption by the corneal epithelium. The threshold UV-B dose for photokeratitis is approximately 40–100 mJ/cm². Under normal NZ summer conditions, this threshold is not reached during typical outdoor exposure, but under 50–100% elevated UV-B, unprotected outdoor workers could reach the threshold within 1–2 hours of midday exposure during summer.↩︎

45. Pterygium prevalence in NZ is higher than in many developed countries due to high ambient UV. Prevalence in Maori and Pacific Island populations is estimated at 5–15%; in NZ European populations, 2–5%. Surgical excision with conjunctival autograft reduces recurrence rates to approximately 5–10% compared with bare sclera excision (30–50% recurrence). See: Hirst, L.W., “The treatment of pterygium,” Survey of Ophthalmology, 2003.↩︎

46. UV-B and cataract risk: McCarty, C.A. and Taylor, H.R., “A review of the epidemiologic evidence linking ultraviolet radiation and cataracts,” Developments in Ophthalmology, 2002. The Chesapeake Bay Watermen Study and Australian studies demonstrate dose-response relationship between cumulative UV-B exposure and cortical cataract risk.↩︎

47. Standard soda-lime glass transmits very little radiation below approximately 300 nm (UV-B) due to absorption by the glass matrix. Transmission increases through the UV-A range (315–380 nm). A standard glass spectacle lens provides meaningful UV-B protection even without deliberate UV-filtering treatment. See: Mainster, M.A. and Turner, P.L., “Ultraviolet-B phototoxicity and hypothetical photomelanomagenesis: intraocular and crystalline lens photoprotection,” American Journal of Ophthalmology, 2010.↩︎